ARTICLE | Clinical News
Esprolol: Began Phase IIb study
June 28, 1999 7:00 AM UTC
Selectus Pharmaceuticals Inc., West Conshohocken, Penn. Product: Esprolol Business: Cardiovascular Therapeutic category: Receptor antagonist Target: Beta adrenergic receptors Description: Sublingual ...